GSK PLC (NYSE:GSK)
$ 45.725 0.065 (0.14%) Market Cap: 93.23 Bil Enterprise Value: 109.53 Bil PE Ratio: 17.98 PB Ratio: 5.35 GF Score: 79/100

GlaxoSmithKline PLC Vaccines Investor Event Transcript

Sep 26, 2019 / 11:30AM GMT
Release Date Price: $43.22 (+1.52%)
Sarah Elton;Farr
GlaxoSmithKline plc - Head of IR

Everyone can take their seats. Roger and the Vaccines team are ready to come and talk to you. We're going live on the webcast, and I will hand over to Roger.

Roger G. Connor
GlaxoSmithKline plc - President of Global Vaccines

Yes. Thank you. Hello, everyone. You're very welcome to Belgium. My name is Roger Connor, and it's my privilege to be the Head of the GSK Vaccines business. I've been in this company just over 20 years. I have worked in manufacturing and supply most of my career actually, and I led our global manufacturing and supply organization for a number of years sitting on the corporate executive team. And it was just a year ago that Emma asked me to become the President of our global Vaccines business. I have to say, I love my job. I think it's incredible, the difference that we get to make to people's lives. We are the world's largest vaccines company, and we estimate that 40% of the world's children receive a GSK vaccine. That's something we are incredibly proud of, and we can't

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot